Parkin cooperates with GDNF/RET signaling to prevent dopaminergic neuron degeneration

Autor: Durga Praveen Meka, Barbara Finckh, Anne Kathrin Müller-Rischart, Margit Miesbauer, Edgar R. Kramer, Prakash Nidadavolu, Jörg Tatzelt, Elisa Motori, Behnam Mohammadi, Konstanze F. Winklhofer, Natalie Rotermund, Anil Annamneedi, Srinivas Kumar Ponna, Mahmoud Bassal, Christian Lohr, Helia Aboutalebi
Jazyk: angličtina
Rok vydání: 2015
Předmět:
physiology [NF-kappa B]
physiology [Phosphatidylinositol 3-Kinases]
endocrine system diseases
pathology [Dopaminergic Neurons]
biosynthesis [Adenosine Triphosphate]
parkin protein
Anxiety
pathology [Parkinsonian Disorders]
Parkin
pathology [Mitochondria]
Mice
Phosphatidylinositol 3-Kinases
Adenosine Triphosphate
Neurotrophic factors
Glial cell line-derived neurotrophic factor
genetics [Glial Cell Line-Derived Neurotrophic Factor]
Mice
Knockout

genetics [Ubiquitin-Protein Ligases]
Ret protein
mouse

biology
Dopaminergic
NF-kappa B
pathology [Nerve Degeneration]
genetics [Proto-Oncogene Proteins c-ret]
General Medicine
Gdnf protein
mouse

Cell biology
Mitochondria
Substantia Nigra
Proto-Oncogene Proteins c-ret
genetics [Parkinsonian Disorders]
Disease Progression
Research Article
Signal Transduction
metabolism [Recombinant Fusion Proteins]
medicine.medical_specialty
endocrine system
deficiency [Proto-Oncogene Proteins c-ret]
Recombinant Fusion Proteins
Ubiquitin-Protein Ligases
Substantia nigra
physiology [Glial Cell Line-Derived Neurotrophic Factor]
Mice
Transgenic

deficiency [Ubiquitin-Protein Ligases]
Cell Line
Parkinsonian Disorders
Internal medicine
Dopaminergic Cell
medicine
Animals
ddc:610
Glial Cell Line-Derived Neurotrophic Factor
genetics [Anxiety]
pathology [Substantia Nigra]
Cell Size
deficiency [Glial Cell Line-Derived Neurotrophic Factor]
Pars compacta
Dopaminergic Neurons
nervous system diseases
Endocrinology
physiology [Proto-Oncogene Proteins c-ret]
nervous system
Rotarod Performance Test
physiology [Ubiquitin-Protein Ligases]
Nerve Degeneration
biology.protein
Exploratory Behavior
Zdroj: The journal of clinical investigation 125(5), 1873-1885 (2015). doi:10.1172/JCI79300
DOI: 10.1172/JCI79300
Popis: Parkin and the glial cell line–derived neurotrophic factor (GDNF) receptor RET have both been independently linked to the dopaminergic neuron degeneration that underlies Parkinson’s disease (PD). In the present study, we demonstrate that there is genetic crosstalk between parkin and the receptor tyrosine kinase RET in two different mouse models of PD. Mice lacking both parkin and RET exhibited accelerated dopaminergic cell and axonal loss compared with parkin-deficient animals, which showed none, and RET-deficient mice, in which we found moderate degeneration. Transgenic expression of parkin protected the dopaminergic systems of aged RET-deficient mice. Downregulation of either parkin or RET in neuronal cells impaired mitochondrial function and morphology. Parkin expression restored mitochondrial function in GDNF/RET-deficient cells, while GDNF stimulation rescued mitochondrial defects in parkin-deficient cells. In both cases, improved mitochondrial function was the result of activation of the prosurvival NF-κB pathway, which was mediated by RET through the phosphoinositide-3-kinase (PI3K) pathway. Taken together, these observations indicate that parkin and the RET signaling cascade converge to control mitochondrial integrity and thereby properly maintain substantia nigra pars compacta dopaminergic neurons and their innervation in the striatum. The demonstration of crosstalk between parkin and RET highlights the interplay in the protein network that is altered in PD and suggests potential therapeutic targets and strategies to treat PD.
Databáze: OpenAIRE